Venkatesan; Aranapakam Mudumbai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Venkatesan; Aranapakam Mudumbai.The latest application filed is for "triazine compounds as pi3 kinase and mtor inhibitors".

Company Profile

0.21.41

Venkatesan; Aranapakam Mudumbai - Rego Park NY
Venkatesan; Aranapakam Mudumbai - Regopark NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 10,022,381 - Venkatesan , et al. July 17, 2	2018-07-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20170224696 - VENKATESAN; Aranapakam Mudumbai ; et al.	2017-08-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20170119778 - VENKATESAN; Aranapakam Mudumbai ; et al.	2017-05-04
Triazine compounds as PI3 kinase and MTOR inhibitors Grant 9,174,963 - Venkatesan , et al. November 3, 2	2015-11-03
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20150011752 - VENKATESAN; Aranapakam Mudumbai ; et al.	2015-01-08
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,859,542 - Venkatesan , et al. October 14, 2	2014-10-14
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20140248239 - VENKATESAN; Aranapakam Mudumbai ; et al.	2014-09-04
Triazine compounds as P13 kinase and MTOR inhibitors Grant 8,748,421 - Venkatesan , et al. June 10, 2	2014-06-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130315865 - VENKATESAN; Aranapakam Mudumbai ; et al.	2013-11-28
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,575,159 - Venkatesan , et al. November 5, 2	2013-11-05
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,445,486 - Venkatesan , et al. May 21, 2	2013-05-21
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130109670 - VENKATESAN; Aranapakam Mudumbai ; et al.	2013-05-02
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20130005723 - Venkatesan; Aranapakam Mudumbai ; et al.	2013-01-03
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,217,036 - Venkatesan , et al. July 10, 2	2012-07-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20110312955 - VENKATESAN; Aranapakam Mudumbai ; et al.	2011-12-22
Triazine compounds as PI3 kinase and mTOR inhibitors Grant 8,039,469 - Venkatesan , et al. October 18, 2	2011-10-18
Bicyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,812,014 - Venkatesan , et al. October 12, 2	2010-10-12
Tricyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,691,842 - Venkatesan , et al. April 6, 2	2010-04-06
3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine And 3-substituted-1h-pyrrolo[3,2-b]pyridine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100061982 - Ayral-Kaloustian; Semiramis ; et al.	2010-03-11
Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors App 20100063023 - Mansour; Tarek Suhayl ; et al.	2010-03-11
Process For The Preparation Of 2,4-dichloro-7h-pyrrolo[2,3h]quinazoline App 20100036123 - Kremer; Kenneth Alfred Martin ; et al.	2010-02-11
(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20100003250 - Chen; Zecheng ; et al.	2010-01-07
3-substituted-1h-indole Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses App 20090311217 - Bursavich; Matthew Gregory ; et al.	2009-12-17
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20090304692 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-12-10
Triazine Compounds As Pi3 Kinase And Mtor Inhibitors App 20090291079 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-11-26
7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS App 20090227575 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-09-10
[a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES App 20090192147 - Ayral-Kaloustian; Semiramis ; et al.	2009-07-30
1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES App 20090192176 - Zask; Arie ; et al.	2009-07-30
3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES App 20090181963 - Dehnhardt; Christoph Martin ; et al.	2009-07-16
PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS App 20090149458 - CHEN; Zecheng ; et al.	2009-06-11
Benzofuranyl- And Benzothienyl- Piperazinyl Quinolines And Methods Of Their Use App 20090054454 - Venkatesan; Aranapakam Mudumbai ; et al.	2009-02-26
Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors App 20090018332 - Kremer; Kenneth Alfred Martin ; et al.	2009-01-15
Tricyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors App 20080318921 - Venkatesan; Aranapakam Mudumbai ; et al.	2008-12-25
Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors App 20080312203 - Venkatesan; Aranapakam Mudumbai ; et al.	2008-12-18
Imidazolopyrimidine Analogs And Their Use As Pi3 Kinase And Mtor Inhibitors App 20080233127 - Bursavich; Matthew Gregory ; et al.	2008-09-25
4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors App 20070232582 - Mansour; Tarek Suhayl ; et al.	2007-10-04
Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use Grant 7,276,603 - Venkatesan , et al. October 2, 2	2007-10-02
Piperidinyl Indole And Tetrohydropyridinyl Indole Derivatives And Methods Of Their Use App 20070225319 - Venkatesan; Aranapakam Mudumbai ; et al.	2007-09-27
Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use Grant 7,235,569 - Venkatesan , et al. June 26, 2	2007-06-26
4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as .beta.-lactamase inhibitors Grant 7,229,983 - Mansour , et al. June 12, 2	2007-06-12
Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression Grant 7,148,235 - Venkatesan , et al. December 12, 2	2006-12-12
Tricyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors App 20060276446 - Mansour; Tarek Suhayl ; et al.	2006-12-07
Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors App 20060276445 - Mansour; Tarek Suhayl ; et al.	2006-12-07
Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors App 20060217361 - Venkatesan; Aranapakam Mudumbai ; et al.	2006-09-28
Bicyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,112,582 - Venkatesan , et al. September 26, 2	2006-09-26
Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors App 20060074064 - Venkatesan; Aranapakam Mudumbai ; et al.	2006-04-06
Tricyclic 6-alkylidene-penems as .beta.-lactamase inhibitors Grant 7,018,997 - Venkatesan , et al. March 28, 2	2006-03-28
Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use App 20050059673 - Venkatesan, Aranapakam Mudumbai ; et al.	2005-03-17
Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use App 20050004162 - Venkatesan, Aranapakam Mudumbai ; et al.	2005-01-06
4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors App 20040214812 - Mansour, Tarek Suhayl ; et al.	2004-10-28
Process for preparing 6-alkylidene penem derivatives App 20040132708 - Abe, Takao ; et al.	2004-07-08
Bicyclic 5-alkylidene-penems as beta lactamases inhibitors App 20040077622 - Venkatesan, Aranapakam Mudumbai ; et al.	2004-04-22
Process for preparing 6-alkylidene penem derivatives App 20040053913 - Abe, Takao ; et al.	2004-03-18
Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors App 20040043978 - Venkatesan, Aranapakam Mudumbai ; et al.	2004-03-04
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl, or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors App 20020188120 - Venkatesan, Aranapakam Mudumbai ; et al.	2002-12-12
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors Grant 6,441,023 - Venkatesan , et al. August 27, 2	2002-08-27
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors App 20020032186 - Venkatesan, Aranapakam Mudumbai ; et al.	2002-03-14
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors App 20020006922 - Venkatesan, Aranapakam Mudumbai ; et al.	2002-01-17
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors Grant 6,197,791 - Venkatesan , et al. March 6, 2	2001-03-06
N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors Grant 6,172,057 - Venkatesan , et al. January 9, 2	2001-01-09
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors Grant 5,929,097 - Levin , et al. July 27, 1	1999-07-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.